Search research articles
Contact Us
Filters
Showing results (51-60 of 191) with videos related to
Page
of 20
Sort By:
Translational Lung Cancer Research
|
February 11, 2021
A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside
Xiaofei Wang, Zengtuan Xiao, Jialin Gong, et al.
Journal of Cellular and Molecular Medicine
|
July 3, 2024
Integrating machine learning and single-cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers
Pengpeng Zhang, Jiaqi Feng, Min Rui, et al.
BMC Cancer
|
November 26, 2025
IGFBP1 facilitates tumor proliferation, invasion and migration by modulating the MAPK-ERK signaling pathway in lung adenocarcinoma
Mengzhe Zhang, Yiying Di, Zuo Liu, et al.
Environmental Toxicology
|
March 15, 2024
Unraveling the role of low-density lipoprotein-related genes in lung adenocarcinoma: Insights into tumor microenvironment and clinical prognosis
Pengpeng Zhang, Xinyi Wu, Dingli Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
December 15, 2010
[Comparative analysis of sleeve resection and pneumonectomy for lung cancer]
Changli Wang, Zhenfa Zhang, Liqun Gong, et al.
Cancer Immunology, Immunotherapy : CII
|
April 5, 2025
Multicenter evaluation of predictive clinical and imaging factors for pathological response in non-small cell lung cancer patients treated with neoadjuvant chemotherapy and immune checkpoint inhibitors
Mengzhe Zhang, Meng Yan, Zekun Li, et al.
Journal of Cancer Research and Clinical Oncology
|
April 5, 2018
Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitors
Chenguang Li, Hailin Liu, Bin Zhang, et al.
Journal for Immunotherapy of Cancer
|
July 31, 2025
Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma
Pengpeng Zhang, Mengzhe Zhang, Jianlan Liu, et al.
Cancer Medicine
|
September 7, 2023
CT-based radiomics model to predict spread through air space in resectable lung cancer
Jialin Gong, Rui Yin, Leina Sun, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2025
Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma
Pengpeng Zhang, Dingli Wang, Guangyao Zhou, et al.
Page
of 20
Search research articles
Search
Showing results (51-60 of 191) with videos related to
Sort By:
Page
of 20
Translational Lung Cancer Research
|
February 11, 2021
A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside
Xiaofei Wang, Zengtuan Xiao, Jialin Gong, et al.
Journal of Cellular and Molecular Medicine
|
July 3, 2024
Integrating machine learning and single-cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers
Pengpeng Zhang, Jiaqi Feng, Min Rui, et al.
BMC Cancer
|
November 26, 2025
IGFBP1 facilitates tumor proliferation, invasion and migration by modulating the MAPK-ERK signaling pathway in lung adenocarcinoma
Mengzhe Zhang, Yiying Di, Zuo Liu, et al.
Environmental Toxicology
|
March 15, 2024
Unraveling the role of low-density lipoprotein-related genes in lung adenocarcinoma: Insights into tumor microenvironment and clinical prognosis
Pengpeng Zhang, Xinyi Wu, Dingli Wang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
December 15, 2010
[Comparative analysis of sleeve resection and pneumonectomy for lung cancer]
Changli Wang, Zhenfa Zhang, Liqun Gong, et al.
Cancer Immunology, Immunotherapy : CII
|
April 5, 2025
Multicenter evaluation of predictive clinical and imaging factors for pathological response in non-small cell lung cancer patients treated with neoadjuvant chemotherapy and immune checkpoint inhibitors
Mengzhe Zhang, Meng Yan, Zekun Li, et al.
Journal of Cancer Research and Clinical Oncology
|
April 5, 2018
Whole-exome sequencing identifies key mutated genes in T790M wildtype/cMET-unamplified lung adenocarcinoma with acquired resistance to first-generation EGFR tyrosine kinase inhibitors
Chenguang Li, Hailin Liu, Bin Zhang, et al.
Journal for Immunotherapy of Cancer
|
July 31, 2025
Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma
Pengpeng Zhang, Mengzhe Zhang, Jianlan Liu, et al.
Cancer Medicine
|
September 7, 2023
CT-based radiomics model to predict spread through air space in resectable lung cancer
Jialin Gong, Rui Yin, Leina Sun, et al.
Journal for Immunotherapy of Cancer
|
February 26, 2025
Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma
Pengpeng Zhang, Dingli Wang, Guangyao Zhou, et al.
Page
of 20